Herberg Samuel, Kondrikova Galina, Hussein Khaled A, Periyasamy-Thandavan Sudharsan, Johnson Maribeth H, Elsalanty Mohammed E, Shi Xingming, Hamrick Mark W, Isales Carlos M, Hill William D
1 Charlie Norwood VA Medical Center, Georgia Regents University , Augusta, Georgia .
Tissue Eng Part A. 2014 Dec;20(23-24):3212-27. doi: 10.1089/ten.TEA.2013.0663.
Skeletal injury is a major clinical challenge accentuated by the decrease of bone marrow-derived mesenchymal stem/stromal cells (BMSCs) with age or disease. Numerous experimental and clinical studies have revealed that BMSCs hold great promise for regenerative therapies due to their direct osteogenic potential and indirect trophic/paracrine actions. Increasing evidence suggests that stromal cell-derived factor-1 (SDF-1) is involved in modulating the host response to the injury. Common problems with BMSC therapy include poor cell engraftment, which can be addressed by total body irradiation (TBI) prior to transplantation. In this study, we tested the hypothesis that direct tibial transplantation of BMSCs drives endogenous bone formation in a dose-dependent manner, which is enhanced by TBI, and investigated the potential role of SDF-1 in facilitating these events. We found that TBI is permissive for transplanted BMSCs to engraft and contribute to new bone formation. Bone marrow (BM) interstitial fluid analysis revealed no differences of SDF-1 splice variants in irradiated animals compared to controls, despite the increased mRNA and protein levels expressed in whole BM cells. This correlated with increased dipeptidyl peptidase IV activity and the failure to induce chemotaxis of BMSCs in vitro. We found increased mRNA expression levels of the major SDF-1-cleaving proteases in whole BM cells from irradiated animals suggesting distinct spatial differences within the BM in which SDF-1 may play different autocrine and paracrine signaling roles beyond the immediate cell surface microenvironment.
骨骼损伤是一个重大的临床挑战,随着年龄增长或疾病发生,骨髓间充质干细胞(BMSC)数量减少会使这一挑战更加突出。大量实验和临床研究表明,BMSC因其直接的成骨潜能和间接的营养/旁分泌作用,在再生治疗方面具有巨大潜力。越来越多的证据表明,基质细胞衍生因子-1(SDF-1)参与调节宿主对损伤的反应。BMSC治疗的常见问题包括细胞植入不佳,这可以通过移植前的全身照射(TBI)来解决。在本研究中,我们验证了以下假设:直接将BMSC胫骨内移植能以剂量依赖方式驱动内源性骨形成,TBI可增强这种作用,并研究了SDF-1在促进这些过程中的潜在作用。我们发现,TBI有利于移植的BMSC植入并促进新骨形成。骨髓(BM)间质液分析显示,与对照组相比,受照射动物中SDF-1剪接变体无差异,尽管全骨髓细胞中其mRNA和蛋白水平有所增加。这与二肽基肽酶IV活性增加以及体外未能诱导BMSC趋化性相关。我们发现,受照射动物全骨髓细胞中主要SDF-1裂解蛋白酶的mRNA表达水平增加,这表明骨髓内存在明显的空间差异,在其中SDF-1可能在紧邻细胞表面微环境之外发挥不同的自分泌和旁分泌信号作用。